These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 32800947)
1. Prostate cancer-derived exosomes promote osteoblast differentiation and activity through phospholipase D2. Borel M; Lollo G; Magne D; Buchet R; Brizuela L; Mebarek S Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165919. PubMed ID: 32800947 [TBL] [Abstract][Full Text] [Related]
2. Effects of phospholipase D during cultured osteoblast mineralization and bone formation. Abdallah D; Skafi N; Hamade E; Borel M; Reibel S; Vitale N; El Jamal A; Bougault C; Laroche N; Vico L; Badran B; Hussein N; Magne D; Buchet R; Brizuela L; Mebarek S J Cell Biochem; 2019 Apr; 120(4):5923-5935. PubMed ID: 30320913 [TBL] [Abstract][Full Text] [Related]
3. Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models. Borel M; Cuvillier O; Magne D; Mebarek S; Brizuela L Mol Cell Biochem; 2020 Oct; 473(1-2):263-279. PubMed ID: 32661773 [TBL] [Abstract][Full Text] [Related]
4. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway. Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720 [TBL] [Abstract][Full Text] [Related]
5. Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation. Noble AR; Maitland NJ; Berney DM; Rumsby MG Br J Cancer; 2018 Jan; 118(2):189-199. PubMed ID: 29136407 [TBL] [Abstract][Full Text] [Related]
6. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines. Zayzafoon M; Abdulkadir SA; McDonald JM J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722 [TBL] [Abstract][Full Text] [Related]
7. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635 [TBL] [Abstract][Full Text] [Related]
8. Phospholipase D and cancer metastasis: A focus on exosomes. Wolf A; Tanguy E; Wang Q; Gasman S; Vitale N Adv Biol Regul; 2023 Jan; 87():100924. PubMed ID: 36272918 [TBL] [Abstract][Full Text] [Related]
9. Exosome Secretion and Epithelial-Mesenchymal Transition in Ovarian Cancer Are Regulated by Phospholipase D. Onallah H; Mannully ST; Davidson B; Reich R Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362078 [TBL] [Abstract][Full Text] [Related]
10. Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1/integrin α4β1 system. Chang AC; Chen PC; Lin YF; Su CM; Liu JF; Lin TH; Chuang SM; Tang CH Cancer Lett; 2018 Jul; 426():47-56. PubMed ID: 29627497 [TBL] [Abstract][Full Text] [Related]
11. Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer. Ye Y; Li SL; Ma YY; Diao YJ; Yang L; Su MQ; Li Z; Ji Y; Wang J; Lei L; Fan WX; Li LX; Xu Y; Hao XK Oncotarget; 2017 Nov; 8(55):94834-94849. PubMed ID: 29212270 [TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory products. Pagel CN; Kularathna PK; Sanaei R; Young ND; Hooper JD; Mackie EJ Prostate; 2022 May; 82(6):723-739. PubMed ID: 35167724 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Kitagawa Y; Dai J; Zhang J; Keller JM; Nor J; Yao Z; Keller ET Cancer Res; 2005 Dec; 65(23):10921-9. PubMed ID: 16322239 [TBL] [Abstract][Full Text] [Related]
14. Exosomal miR-1275 Secreted by Prostate Cancer Cells Modulates Osteoblast Proliferation and Activity by Targeting the SIRT2/RUNX2 Cascade. Zou Z; Dai R; Deng N; Su W; Liu P Cell Transplant; 2021; 30():9636897211052977. PubMed ID: 34689576 [TBL] [Abstract][Full Text] [Related]
15. Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice. Furesi G; de Jesus Domingues AM; Alexopoulou D; Dahl A; Hackl M; Schmidt JR; Kalkhof S; Kurth T; Taipaleenmäki H; Conrad S; Hofbauer C; Rauner M; Hofbauer LC Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163219 [TBL] [Abstract][Full Text] [Related]
16. Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p. Yu L; Sui B; Fan W; Lei L; Zhou L; Yang L; Diao Y; Zhang Y; Li Z; Liu J; Hao X J Extracell Vesicles; 2021 Jan; 10(3):e12056. PubMed ID: 33489015 [TBL] [Abstract][Full Text] [Related]
17. Exosomes derived from mineralizing osteoblasts promote ST2 cell osteogenic differentiation by alteration of microRNA expression. Cui Y; Luan J; Li H; Zhou X; Han J FEBS Lett; 2016 Jan; 590(1):185-92. PubMed ID: 26763102 [TBL] [Abstract][Full Text] [Related]
18. Lack of effective translational regulation of PLD expression and exosome biogenesis in triple-negative breast cancer cells. Gomez-Cambronero J Cancer Metastasis Rev; 2018 Sep; 37(2-3):491-507. PubMed ID: 30091053 [TBL] [Abstract][Full Text] [Related]
19. Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6. Schmitt J; Noble A; Otsuka M; Berry P; Maitland NJ; Rumsby MG Br J Cancer; 2014 Oct; 111(8):1646-56. PubMed ID: 25137020 [TBL] [Abstract][Full Text] [Related]
20. Proliferative and metastatic roles for Phospholipase D in mouse models of cancer. Roth E; Frohman MA Adv Biol Regul; 2018 Jan; 67():134-140. PubMed ID: 29154090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]